Is Ozempic the Most Effective Weight Loss Drug?
Diabetes-turned-weight loss drug Mounjaro helped patients shed pounds nearly twice as fast as its ultra-popular counterpart Ozempic, according to a study released Monday. The extensive study of more than 18,000 overweight or obese people found that those taking once-weekly injections of Eli Lilly’s Mounjaro were able to melt off 15.2% of their weight — compared to 7.9% for those on Novo Nordisk’s Ozempic.
There was also a stark contrast in results at the three-month and six-month marks, according to the study by Truveta Research. At the three-month mark, patients taking Mounjaro lost 5.9% of their weight, compared with 3.6% for those on Ozempic, the study showed. At six months, people taking Mounjaro shed 10.1% of their weight, while patients on Ozempic lost 5.9%.
Eli Lilly’s Mounjaro patients “were significantly more likely to achieve 5%, 10% and 15% weight loss and experience larger reductions to weight at three, six and 12 months,” than those who took Ozempic, the report concluded. Over the entire time period analyzed — between May 2022 and September 2023 — researchers found that patients taking Mounjaro were three times more likely to lose 15% of their weight than those on Ozempic.
Excerpted from the New York Post
